Market Updates
India Movers: Aurobindo Pharma, GPT Healthcare, IFCI, SBI Cards, Star Health, UltraTech, Vodafone Idea
Arun Goswami
20 Mar, 2024
Mumbai
IFCI Ltd. declined 2.7% to ₹37.55, and the company's board approved the stake sale to the company's promoter, the Ministry of Finance, for ₹500 crore.
NBCC India Ltd. decreased 2.1% to ₹109.20, and the construction company's subsidiary received an order worth ₹14 crore.
GPT Healthcare fell 0.1% to ₹167.30 after the hospital operator reported rising revenue and earnings in the December quarter.
Revenue increased 4.2% to 96.6 crore, and net profit rose 37% to 11.5 crore from a year ago, respectively.
Star Health & Allied Insurance decreased 1.4% to ₹545.05, and ICICI Prudential acquired a 0.61% stake, or 35,7 lakh shares, in the company at an average price of ₹540 per share.
Aurobindo Pharma dropped 2.5% to ₹989.80, and the generic drug maker received approval from the U.S. drug regulator for mometasone furoate monohydrate to treat itching skin conditions in the nasal spray format.
SBI Cards decreased 0.2% to ₹700.0, and the financial service company declared an interim dividend of ₹2.50 per share.
Vodafone Idea eased 3% to ₹12.75, and ATC Telecom asked the embattled telecom company to convert its ₹1,440 crore worth of convertible debentures to common shares.
UltraTech Cement inched lower by 1.4% to ₹9,475.0, and the competition commission approved the company's purchase of the cement business of Kesoram Industries.
Annual Returns
| Company | Ticker | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|
Earnings
| Company | Ticker | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|